ACIU
ACIU
NASDAQ · Biotechnology

Ac Immune Sa

$2.36
+0.04 (+1.72%)
As of Aug 8, 2:00 AM ET ·
Financial Highlights (FY 2026)
Revenue
3.59M
Net Income
-70,707,788
Gross Margin
Profit Margin
-1,971.7%
Rev Growth
-2.9%
D/E Ratio
0.10
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 67.7% 67.7%
Operating Margin -1,940.0% -1,746.0% 0.2% 0.2%
Profit Margin -1,971.7% -1,873.1% 0.2% 0.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.59M 3.70M 119.79M 119.57M
Gross Profit 81.15M 81.00M
Operating Income -69,647,736 -64,541,765 217.2K 194.6K
Net Income -70,707,788 -65,524,103 199.8K 200.3K
Gross Margin 67.7% 67.7%
Operating Margin -1,940.0% -1,746.0% 0.2% 0.2%
Profit Margin -1,971.7% -1,873.1% 0.2% 0.2%
Rev Growth -2.9% -2.9% -0.9% +8.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 10.97M 10.97M 114.17M 132.63M
Total Equity 108.36M 108.36M 166.00M 182.25M
D/E Ratio 0.10 0.10 0.69 0.73
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -67,067,226 -65,603,237 316.5K 305.4K
Free Cash Flow 248.3K 178.6K